Abravanel, D. L., Weipert, C., Margolis, M., Placido, P. D., Morganti, S., Giordano, A., Fanucci, K., Priedigkeit, N., Baral, S., Smith, K., Patel, A., Kirkner, G. J., Stever, C., Suggs, G. L., Snow, C., Tolaney, S. M., Lin, N. U., Jeselsohn, R. (2026). Liquid-based methylation profiling of molecular breast cancer subtypes (MBS) in hormone receptor positive (HR+) metastatic breast cancer (MBC) treated with CDK4/6 inhibitor (CDK4/6i).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1095